SCHEMBL7248747

SCHEMBL7248747

OCCc1cccc(-c2ccc(I)cc2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACMSD Q8TDX5 2/20 0.54
▸ CDK8 P49336 1/20 0.49
▸ MAP4K4 O95819 1/20 0.49
▸ PRKCI P41743 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.43
▸ CYP4F2 P78329 2/20 0.41
▸ CYP4A11 Q02928 2/20 0.41
▸ MMP3 P08254 1/20 0.41
▸ BCL2 P10415 1/20 0.40
▸ BACE1 P56817 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ ALOX5 P09917 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ GGPS1 O95749 1/20 0.38
▸ AGXT P21549 2/20 0.38
▸ GPR84 Q9NQS5 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5865105 0.84 TDP1 (0.62) ACMSDCDK8MAP4K4PRKCITDP1
SCHEMBL7815680 0.81 ACMSD (0.54) ACMSDCDK8MAP4K4PRKCITDP1
SCHEMBL2571534 0.81 TAAR1 (0.55) ACMSDCDK8MAP4K4PRKCITDP1
SCHEMBL18069884 0.81 AGXT (0.57) ACMSDCDK8MAP4K4PRKCITDP1
SCHEMBL2186740 0.78 TDP1 (0.52) ACMSDTDP1CYP4F2CYP4A11BACE1
SCHEMBL1138646 0.78 PRKCI (0.73) ACMSDCDK8MAP4K4PRKCITDP1
SCHEMBL2652456 0.77 AGXT (0.60) ACMSDMAP4K4PRKCIAGXT
SCHEMBL7247547 0.77 ACMSD (0.50) ACMSDCDK8MAP4K4PRKCITDP1
SCHEMBL3238340 0.76 ACMSD (0.52) ACMSDCDK8MAP4K4PRKCICYP4F2
SCHEMBL3947358 0.75 MEN1 (0.55) ACMSDCYP4F2CYP4A11ALDH1A1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030013883-A1 Tropane analogs binding to monoamine transporters NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-01-16 — — US disclosed
US-6365125-B1 USING ORGANOTIN COMPOUND MAP MEDICAL TECHNOLOGIES OY (FI) 2002-04-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030013883-A1 Tropane analogs binding to monoamine transporters SLC6A3, SLC6A2, SLC6A4 ACMSD 3231/4885CDK8 3921/4885MAP4K4 4677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback